Study shows promising results for immunotherapy targeting skin cancer
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
Apr 25, 2023
0
72
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
Apr 25, 2023
0
72
It's only April, but many people across the country and the globe are already enjoying summerlike temperatures. But getting out in the sun also increases your risk of getting skin cancer.
Apr 21, 2023
0
3
Cutaneous melanoma, the most aggressive form of skin cancer, is the fifth most diagnosed cancer in Europe and one of the most frequent causes of cancer death, with incidence and mortality trends on the rise. While the development ...
Apr 20, 2023
0
2
Clinical eligibility guidelines determine the criteria by which patients are selected for various medical procedures. But strict reliance on established guidelines can overlook patients who might benefit from a procedure, ...
Apr 19, 2023
0
6
Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation ...
Apr 17, 2023
0
2
Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded to immunotherapy (pembrolizumab) alone, suggesting that many patients could avoid the risk for toxicity from combination ...
Apr 17, 2023
0
2
In mice with melanoma, probiotic bacteria travel from the gut and establish in tumors, where they directly stimulate immune cells to make cancer immunotherapy more effective, according to a new study led by University of ...
Apr 6, 2023
0
132
Even as pancreatic cancer treatments improve, only about 9% of patients survive past five years. Researchers have searched unsuccessfully to find genetic differences that explain why some patients survive long term and some ...
Apr 3, 2023
0
72
Atopy is associated with a reduction in the risk for melanoma, according to a study published online Feb. 28 in Melanoma Research.
Mar 31, 2023
0
2
A novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous (IV) immunotherapy was safe and improved survival in a subset of patients with leptomeningeal disease (LMD) from ...
Mar 30, 2023
0
21